Zealand Pharma A/S (OTCMKTS:ZLDPF) Trading Up 8% – Here’s What Happened

Zealand Pharma A/S (OTCMKTS:ZLDPF)’s share price was up 8% during mid-day trading on Thursday . The stock traded as high as $114.49 and last traded at $114.49. Approximately 337 shares changed hands during trading, a decline of 83% from the average daily volume of 1,958 shares. The stock had previously closed at $106.00.

Analyst Upgrades and Downgrades

Separately, JPMorgan Chase & Co. started coverage on shares of Zealand Pharma A/S in a report on Friday, November 8th. They issued an “overweight” rating on the stock.

Zealand Pharma A/S Price Performance

The company’s 50-day simple moving average is $112.06 and its 200-day simple moving average is $118.38. The company has a current ratio of 35.49, a quick ratio of 35.49 and a debt-to-equity ratio of 0.03.

Zealand Pharma A/S Company Profile

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon.